An inverse metabolic engineering approach for the design of an improved host platform for over-expression of recombinant proteins in  by unknown
Ghosh et al. Microbial Cell Factories 2012, 11:93
http://www.microbialcellfactories.com/content/11/1/93RESEARCH Open AccessAn inverse metabolic engineering approach
for the design of an improved host platform
for over-expression of recombinant
proteins in Escherichia coli
Chaitali Ghosh, Rashmi Gupta and Krishna Jyoti Mukherjee*Abstract
Background: A useful goal for metabolic engineering would be to generate non-growing but metabolically active
quiescent cells which would divert the metabolic fluxes towards product formation rather than growth. However,
for products like recombinant proteins, which are intricately coupled to the growth process it is difficult to identify
the genes that need to be knocked-out/knocked-in to get this desired phenotype. To circumvent this we adopted
an inverse metabolic engineering strategy which would screen for the desired phenotype and thus help in the
identification of genetic targets which need to be modified to get overproducers of recombinant protein. Such
quiescent cells would obviate the need for high cell density cultures and increase the operational life span
of bioprocesses.
Results: A novel strategy for generating a library, consisting of randomly down regulated metabolic pathways in
E. coli was designed by cloning small genomic DNA fragments in expression vectors. Some of these DNA fragments
got inserted in the reverse orientation thereby generating anti-sense RNA upon induction. These anti-sense
fragments would hybridize to the sense mRNA of specific genes leading to gene ‘silencing’. This library was first
screened for slow growth phenotype and subsequently for enhanced over-expression ability. Using Green
Fluorescent Protein (GFP) as a reporter protein on second plasmid, we were able to identify metabolic blocks
which led to significant increase in expression levels. Thus down-regulating the ribB gene (3, 4 dihydroxy-2-
butanone-4-phosphate synthase) led to a 7 fold increase in specific product yields while down regulating the
gene kdpD (histidine kinase) led to 3.2 fold increase in specific yields.
Conclusion: We have designed a high throughput screening approach which is a useful tool in the repertoire of
reverse metabolic engineering strategies for the generation of improved hosts for recombinant protein expression.
Keywords: Recombinant protein, Inverse metabolic engineering, Escherichia coli, Improved host platformBackground
Improvement of metabolic phenotype through directed
genetic modifications is the main goal of metabolic en-
gineering [1-4]. The classical approach of metabolic en-
gineering requires a detailed knowledge of enzyme
kinetics, the system network, and intermediate pools
involved, and on this basis, a genetic manipulation is
proposed for some presumed benefits. Recent progress
in molecular genetics methods makes it possible to* Correspondence: kjmukherjee@mail.jnu.ac.in
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reproduction in any medium, provided the orknockout or over-express targeted genes in most microor-
ganisms [5-9]. A key question in metabolic engineering is
how to identify gene targets that have direct or indirect
impact on a particular phenotype of interest [10].
For the over-production of metabolites the issue is
comparatively straight forward since only the regulatory
blocks and bottlenecks in the specific pathway involved
in product synthesis need to be removed. Secondly, the
supply of precursor metabolites to the pathway need to
be enhanced thereby improving the metabolic flux in the
pathways. However, for products like recombinantLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the transcriptional/translational mechanism all of which
are coupled to the growth process. Many metabolic
engineering approaches have therefore attempted to
enhance both growth and recombinant protein produc-
tion in E. coli [11,12]. One approach has been to supple-
ment the genes which get down-regulated due to the
stress associated with recombinant protein expression
[13]. Similarly key factors which has impact on growth
and expression yield, like glycolysis and Tri Carboxylic
Acid (TCA) cycle enzymes, ATPase’s, RNA polymerases
etc. have been co-expressed [14-16].
A novel alternative strategy to design overproducers of
the recombinant product would be to make these precur-
sors available specifically for product rather than biomass
formation. We therefore decided to design a strategy to
screen for metabolically active but non-growing quiescent
cells which have been earlier shown to be more effective for
recombinant protein production [17].
The concept of inverse metabolic engineering involves
first to identify the desired phenotype, then to determine
environmental or genetic conditions that confer this pheno-
type, and finally to alter the phenotype of the selected host
by genetic manipulation [18,19]. In this study, we adopted
this approach where an E. coli genomic library was
screened to obtain quiescent cells which might be better
producers of recombinant proteins. For this, we randomly
and partially down-regulated the biosynthetic pathways in
the cell, in order to identify those blockages which help in
diverting the metabolic flux away from growth. Cells with
slow growth phenotype or growth stoppage were then
screened for enhanced protein expression capability. An
additional advantage of non-growing, quiescent cells is that
they can increase the operational life span of bio-processes
and improve process economics by decoupling product for-
mation from cell growth [20].
In this study an E. coli genomic library was prepared in a
pRSET A vector having a strong promoter as well as in
pBAD33 having a comparatively weaker promoter because
even a small down regulation of some genes can have
significant effects. Screening of the genomic library by dif-
ferent approaches (slow growth or enhanced GFP fluores-
cence) led to the identification of clones with different
down-regulated genes which blocked growth and simultan-
eously improved recombinant protein expression.
Results and discussion
Identification of metabolic pathways which lead to
'no growth’ or slow-growth phenotype through genomic
library screening
We constructed a library consisting of a set of clones
with metabolic pathways which were ‘knocked-down’
rather than ‘knocked-out’, allowing us to include the role
of essential genes. In our study the strategy adopted wasto clone small fragments of genomic DNA (~ 200–800
bases), the idea being that some of these DNA fragments
would get inserted in an opposite orientation (compared
to the coding strand) in the expression vector. On
induction, the RNA produced would be complimentary
to the mRNA (of a functional protein) which would then
hybridize leading to (partial) silencing of the gene. In
eukaryotic systems an ideal antisense could be as short
as a 22–25 bp fragment (as then a dicer molecule can
act, leading to RNAi). But in prokaryotic systems, RNAi
is absent and not many studies have been done on the
antisense mechanism. So by choosing a 200–800 bp
fragment we attempted to ensure that at least partial
gene silencing would take place.
The concept of inverse metabolic engineering was
used to screen this library for the desired ‘no-growth’
phenotype and then to identify the genetic factors that
confer this phenotype. We were interested in a
‘no-growth’ or ‘slow-growth’ phenotype where the meta-
bolic activity was undiminished; the rationale being such
clones would divert the metabolic flux away from bio-
mass formation and towards product synthesis.
Construction of the antisense library in pRSET A vector
Genomic DNA fragments of sizes ranging from 200–
800 bp (as we required only a part of the gene which
would act in an antisense fashion to block transcription)
were isolated after an optimized partial digestion of the
E. coli genomic DNA and subsequently ligated into a
high copy number vector (pRSET A) with a strong T7
promoter. The constructed shotgun library in pRSET A
was transformed into E. coli BL21 pLysS strain.
A two step screening strategy was used. In the first step,
more than 8000 transformants were screened. Preliminary
screening was done on plates. Each transformant was rep-
lica plated and only those clones were selected which
upon Isopropyl β-D-1-thiogalactopyranoside (IPTG) in-
duction grew very slowly on plates. After first screening,
728 clones were isolated and a second round of screening
was done on LB agar plates. Finally 70 clones were picked
and the metabolic activity of these slow growing transfor-
mants were checked in shake flask cultures containing
M9 media (supplemented with glucose), by looking at
rates of decline of glucose in the medium, post IPTG in-
duction. Our aim was to identify clones with negligible
growth rate but unimpaired metabolic activity. 17 trans-
formants were finally selected with this desirable pheno-
type where it was expected that the metabolic flux would
possibly get diverted towards recombinant protein expres-
sion instead of growth. Shake flask studies of all these 17
clones were done in different media (LB, TB & M9) where
a similar retardation in growth was observed. As is clear
from Figure 1 significant growth retardation was observed
post induction compared to the uninduced cultures.
Figure 1 Growth profiles of the clones in LB media under T7 promoter of pRSET A, in the host BL21 pLysS. (A) E48 (yidE); (B) EN34 (mfd);
(C) MN45 (aroC); (D) GN11 (ribB); (E) CN38 (cysN); and (F) BN43 (kdpD) (G) GN35; (H) G18 (galT); (I) G3 (yijE); (J) H36 (rpsU); (K) I7 (wzyE); and (L)
H7 (ynaA) (M) H30 (yrfD); (N) G15 (ygcQ); (O) G20 (fdnG); (P) A50 (gpt) and; and (Q) F4 (yjgF) under (♦) uninduced; and (■) IPTG induced condition
respectively.
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search against the E. coli genome database. The lists of
identified genes are given in Table 1. The details of the
genes were collected from the PEC (Profiling of E. coli
Chromosome) and Ecocyc database.These 17 clones were co-transformed with a second
plasmid pBAD33-GFP, where the GFP gene was cloned
under the arabinose promoter and had a compatible p15
‘ori’ with pUC ‘ori’ of pRSET A. This GFP reporter gene
was used to check whether the antisense expression (while
Table 1 List of transcripts whose blockage leads to growth stoppage
Transcript name Gene name Size (bp) Known or putative function of the gene product Orientation Essential/
Non essential
GN35 (T7) - 221 Ketoacid-binding protein Reverse Non-essential
CN38 (T7) cysN 567 Adenosine 5’ phosphosulphate kinase sulfate adenylyltransferase
subunit 1
Same direction Non-essential
BN43 (T7) kdpD 568 Sensory histidine kinase Reverse Non-essential
GN11 (T7) ribB 403 3,4 dihydroxy-2-butanone-4-phosphate synthase Reverse Non-essential
EN34 (T7) mfd 587 Transcription repair coupling factor Same direction Non-essential
MN45 (T7) aroC 190 Chorismate synthase Reverse Non-essential
G3 (T7) yijE 379 Predicted permease Reverse Non-essential
A50 (T7) gpt 141 Xanthine-guanine phosphoribosyl transferase Reverse Non-essential
F4 (T7) yjgF 122 Ketoacid binding protein Reverse Non-essential
H36 (T7) rpsU 422 Acid resistant protein Same direction Non-essential
E48 (T7) yidE 350 Predicted transporter Reverse Non-essential
G15 (T7) ygcQ Predicted electron transfer flavoprotein, NAD/FAD binding Same direction Non-essential
G18 (T7) galT 375 Galactose −1 phosphate uridylyltransferase Reverse Non-essential
G20 (T7) fdnG 720 Formate dehydrogenase- N,alpha subunit,nitrate inducible Reverse Non-essential
H7 (T7) ynaA 876 Conserved hypothetical protein: Rac prophage Reverse Non-essential
H30 (T7) yrfD 769 Reverse Non-essential
I7 (T7) wzyE 770 Predicted Wzy protein involved in ECA polysacharide Same direction Non-essential
L27 (ara) - 639 Conserved hypothetical protein Reverse Non-essential
A17 (ara) bioF 414 Predicted methyltransferase, enzyme of biotin synthesis Reverse Non-essential
A29 (ara) kdpF 289 2-octaprenylphenol hydroxylase enzyme Reverse Non-essential
F50 (ara) - 313 iro p300 Reverse Non-essential
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combinant protein. All these experiments were done in
LB media. For all the 17 clones one flask was induced only
with 0.02% of arabinose (control), while the second test
flask was co-induced with both IPTG and arabinose, to
check the effect of the antisense transcript on GFP expres-
sion. A third flask for all the co-transformants was kept
uninduced to observe the effect if any, of leaky expression
(2nd control). The library contained large number of ran-
dom inserts in pRSET A (which did not show any affect)
which essentially served as a negative control.
Figure 2 (A,B,C) shows the effect of co-expression
of clone GN11 having the anti-sense of ribB gene
(rib-3, 4 dihydroxy-2-butanone-4-phosphate synthase).
In Figure 2B the uninduced culture had a basal level
GFP expression of 5 to 7 AU while GFP expression in
the ara induced control culture increased linearly from
6 to 39 AU in 8 hours post induction. In the test system
the fluorescence of the co-induced culture overtook the
control flask after 2 hours to give a final fluorescence of
53 AU demonstrating the positive effect of antisense
induction on GFP expression. Since the final biomass
concentrations obtained in the test culture was signifi-
cantly lower, the specific product yield was much higherat 347 AU/g DCW, a 7 fold increase over the control
culture (47 AU/g DCW) (Figure 2C).
Figure 2 (D,E,F) shows the co-expression of the clone
EN34 coding for mutation frequency decline (mfd) protein.
In Figure 2E the uninduced flask showed a basal level
expression of 16.9 AU throughout the cultivation. The
control flask showed a linear increase from 10 AU to
54 AU in 8 hours. However, while the expression was ini-
tially low in the co-induced culture, it overtook the control
flask after 3 hours and gave a final GFP fluorescence of
72 AU. The specific product yield of arabinose induced
GFP was found to be 88 AU/gm DCW in the 8th hour post
induction in the control culture whereas in the arabinose
and IPTG induced culture it was calculated to be 378 AU/
gm DCW which was 4 fold higher (Figure 2F).
Similar studies were conducted with the rest of the 15
clones. However, not all the clones gave such a dramatic
increase in the specific product yield though we did ob-
serve a significant increase in specific product yield in
some cases which are listed in Table 2.
Construction of the antisense library in pBAD33
In the previous screening strategy we over-expressed the
transcripts under the strong T7 promoter, which has
 A B  C 
D E F
Figure 2 Time profiles of growth, Fluorescence spectra and Specific product yields of GN11 (ribB) in A, B, and C and EN34 (mfd) in D,
E, and F respectively in LB media. (▲) uninduced; (■) induced with arabinose; (♦) induced with arabinose and IPTG.
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cells and also the expression of T7 RNA polymerase leads
to growth retardation [21,22]. This would mask the true
growth retardation due to the anti-sense effect of the tran-
scripts. Secondly, since the anti-sense works at the RNATable 2 Specific product yield (AU/gm DCW) of various
clones under three different conditions, uninduced,
induced with arabinose and induced with arabinose and
IPTG both (6 hrs post induction)










EN34 (mfd) 362 91 14
G18 (galT) 76 227 18
GN35 89 244 9
GN11 (ribB) 347 47 8
MN45 (aroC) 67 199 25
BN43 (kdpD) 256 67 10
b) Clones in pBAD 33
A17 (bioF) 125 181 9
A29 (kdpF) 681 79 5
F50 225 207 10
L27 175 175 13level we should use only a transcriptional vector and not an
expression vector to rule out the possibility that the toxicity
of a randomly expressed polypeptide is responsible for
growth retardation. Thirdly, hyper expression of the anti-
sense RNA seems to be a clumsy approach to block and/or
down-regulate gene expression (even though this was pri-
marily a screening strategy for identifying potential targets
for manipulation). We therefore chose a much better regu-
lated transcriptional vector for the construction of a second
library which would identify targets where even a partial
down-regulation would lead to diversion of metabolic flux
towards product synthesis.
The genomic library was prepared under the ara pro-
moter in pBAD33 (a transcriptional vector), which is a
tightly regulated promoter. Moreover as we were not
constrained to use the BL21 (DE3) strain we chose
E. coli DH5α since it has superior transformation effi-
ciency and is much more stable strain for retaining plas-
mids. A dual plasmid system was used to directly screen
for the desired phenotype. Competent DH5α cells pre-
transformed with a plasmid pNER31 (having GFP under
the lac promoter) was used for co-transformation with
the genomic library. This allowed us to directly screen
for the over-expressing phenotype. Upon co-induction
of the transcripts, we screened for colonies exhibiting in-
tense green color of GFP (under UV) compared to the
control colonies in the plate. More than 30,000
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clones (Table 1), exhibiting higher GFP expression was
selected for further studies. Shake flask studies on these
clones were done in different media LB, TB, M9 along
with appropriate controls.
We first needed to factor out the effect of GFP expres-
sion on growth retardation by comparing the growth
of the uninduced culture with the IPTG induced culture. A
very slight decline in growth was observed post induc-
tion in LB media which is typical of GFP induced cul-
tures. However when the second, anti-sense gene
carrying plasmid, was induced by arabinose a significant
drop in growth was observed. The growth profile of the co-
induced culture was compared with the control culture
where only GFP was induced. We observed that the growth
declined sharply in all the co-induced cultures (Figure 3).
Comparing the product profile of kdpF (2-octaprenyl-
phenol hydroxylase enzyme) antisense expressing clone
A29, we observed that, the specific product yield of theA            
C                                                                     
Figure 3 Growth profiles of the clones in LB media under ara prom
(C) A29 (kdpF); (D) F50 under (♦) uninduced; (■) induced with arabinose; (▲
condition respectively.co-induced culture was 8.4 fold higher than the control
culture which was induced with IPTG only (Figure 4).
Co-expression studies were also done with rest of the 3
clones (data not shown).
One of the open questions in the quest for improved
host platforms is how targets are to be identified which
confer the desired phenotype, given the lack of a compre-
hensive kinetic model for E. coli and the absence of
detailed information for the regulatory mechanism, which
operate inside the cells. There are therefore several
approaches for the modifications of the E. coli host to
achieve the desired goal [23-25]. In our case the design
strategy was essentially a high throughput screen which
helped us select better producers. It is interesting to note
that all the selected genes were non-essential and also not
directly linked to either growth or product formation.
For example, the selected clone GN11 contained an
insert of 403 bp of the ribB gene (3, 4 dihydroxy-2-buta-
none-4-phosphate synthase) in the reverse direction.B                                                           
  D 
oter of pBAD33, in the host DH5α. (A) A17 (bioF); (B) L27;
) induced with IPTG and (×) induced with arabinose and IPTG
 A B  C 
Figure 4 Time profiles of growth, Fluorescence spectra and Specific product yields of A29 (kdpF) in A, B, and C respectively in LB
media. (▲) uninduced; (■) induced with IPTG; (♦) induced with arabinose and IPTG.
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ring of riboflavin [26,27]. It is reported that ribB mutant
E. coli leads to slow growth but remains metabolically
active which corroborates our studies [28]. However the
discovery that blocking the gene ribB can help divert the
metabolic flux towards recombinant protein production
was both non obvious and counter intuitive. Similarly,
clone BN43 coded for a protein KdpD (sensory histidine
kinase) which is expressed during osmotic shock and is
otherwise nonessential. Clearly in this case there is no
direct link to the gene function and the observed chan-
nelization of metabolic flux towards recombinant pro-
tein production. In the case of clone MN45 which
contained part of the antisense aroC (chorismate syn-
thase gene, which catalyzes the formation of chorismate
in aromatic amino acid biosynthesis) its blockage should
ideally lead to a decrease in the biosynthetic pathways
involved in growth. However, an exact estimate of the
growth inhibition is difficult given that complex nitrogen
sources are present in the medium which can supply the
growing cell with the desired amino acids. The fact that
blocking chorismate synthase led to a complete growth
stoppage was interesting and points to the criticality of
even single metabolic reactions in growth. All these
results underscore the fact that there is no direct link at
the pathway level between gene function and observed
phenotype which could possibly be the result of a com-
plex regulatory response within the cell.
Conclusion
In a novel approach towards the design of an ideal host
platform for the over-expression of recombinant pro-
teins, two different high throughput screening strategies
were designed to identify genes whose down-regulation
would lead to a slow growth phenotype and also possibly
divert the metabolic flux towards over-expression of re-
combinant proteins. The leads obtained did not rely on
a priori knowledge of the regulated and interconnected
nature of the E. coli’s metabolic network. At a practicallevel we were able to obtain very useful targets for gene
knock-out/knock-down which would enable the design
of better hosts for protein expression. It would be inter-
esting to study the combined and synergistic effect of
these identified blocks. At a more fundamental level a
detailed analysis of the phenotypic affects of these meta-
bolic blocks can lead to a better understanding of the
regulatory mechanisms in the E. coli network.
Materials and methods
Growth media and antibiotics
Media and bulk chemicals were purchased from local
manufacturers, Himedia, Qualigens, Difco and MERCK.
Media used were Luria Broth [LB] (bactotryptone 10 g/l,
yeast extract 24 g/l and NaCl 15 g/l), Terrific Broth [TB]
(YE 24 g/l, tryptone 12 g/l, glucose 0.5% in which 2.31 g/l
KH2PO4 and 12.54 g/l K2HPO4 were added after autoclav-
ing separately), and minimal media [M9] (NaCl 0.5 g/l,
NH4Cl 1 g/l, K2HPO4 3 g/l, 1 M CaCl2 0.1 ml/l, 1 M
MgSO4 2 ml/l and 20% glucose 10 ml/l). Antibiotics used
were ampicillin 100 μg/ml (1X), kanamycin 50 μg/ml (1X)
and chloramphenicol 30 μg/ml (1X).
Bacterial strains and plasmids
The T7 based expression vector pRSET A (ampicillin,
Invitrogen) which had pUC ‘ori’, was used in these stud-
ies. pBAD33 (chloramphenicol, Beckwith) [29] having
p15 ‘ori’ with ara promoter and compatible with pRSET
A, was used for expression of GFP gene (used as a re-
porter protein) and the construction of second library.
The plasmids were maintained and expressed in E. coli
DH5α cells. E. coli BL21 (DE3) from stratagene (USA)
and E. coli BL21 (DE3) pLysS were used for expression
studies. Strain JM109 (Promega, USA) was used for the
genomic library preparation. pNER31 (ampicillin) having
GFP gene under ‘lac’ promoter and induced by IPTG,
was gifted by Summers, Cambridge, UK and pET14b-
GFP (ampicillin) where GFP gene was cloned under T7
promoter, was gifted by J. Singh, ICGEB, India.
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A and pBAD33
Genomic DNA was isolated from JM109 by the Hexade-
cyltrimethylammonium bromide (CTAB) method. This
was partially digested with either SauIIIA or NlaIII both
four base cutters. The expression vectors pRSET A and
pBAD33 were digested with BglII and SphI which gener-
ate compatible cohesive ends with SauIIIA and NlaIII
respectively. These linearised vector fragments were Calf
Intestinal Alkaline Phosphatase (CIAP) treated to pre-
vent self ligation and ligated with the digested and gel
eluted genomic fragments of size ranging from 200 to
800 bp. The ligation mixture was used to transform
electrocompetent BL21(DE3) pLysS and DH5α cells
respectively and plates were incubated at 37°C over-
night. Approximately 8000 and 30,000 colonies were
obtained in each library respectively. The quality of
the library that was constructed was checked by pick-
ing a few colonies and checking for the insert size by
colony PCR.Screening of the library by two different approaches
A preliminary screening of the pRSET A vector library was
done on LB agar plates. Replica plating was done onto two
different plates. One plate containing IPTG was considered
as induced and the second plate without IPTG was consid-
ered as control. Slow growing colonies upon induction
were identified and there growth profile was determined by
performing shake flask studies in different media viz. LB,
TB and M9.
For the second library under pBAD33, a co-transformation
protocol was followed where electrocompetent cells of
DH5α already containing the pNER31 plasmid (with GFP)
was prepared by glycerol wash method and electroporated
with the ligation mixture containing the genomic library.
Primary screening was done on LB agar plates by induction
of both the plasmids with IPTG (1 mM final concentration)
and arabinose (0.02%, final concentration). Colonies with
enhanced fluorescence were picked, and the genomic frag-
ments cloned in the second plasmid (containing the library)
which were responsible for enhanced fluorescence, was
determined by sequencing. The growth and product profiles
were determined for the selected clones by shake flask stud-
ies which were done in M9, TB and LB media.
Selected clones which showed enhanced fluorescence
upon induction were grown overnight with shaking at
37°C in 3 ml LB tubes. Secondary inoculation was done
by adding 100 μl of overnight grown culture in 10 ml of
LB, TB and M9 medium in 100 ml flasks. After 1.5
hours when the OD600 of 0.3-0.5 was attained, cultures
were induced by adding 1 mM IPTG (final concentra-
tion). After induction, the OD600 was monitored at regu-
lar intervals.For measuring the metabolic activity of non growing
cells in minimal media, 200 μl of samples were taken at
regular intervals post induction. These samples were
centrifuged at 13,200 rpm for 2 minutes and the super-
natant was stored at 4°C. Glucose levels were estimated
by the 3, 5-Dinitrosalicylic acid (DNSA) method.
The expression of GFP was monitored by Varian
(Carry Eclipse) Fluorescence Spectrophotometer with an
excitation wavelength of 488 nm and emission wave-
length of 514 nm.
The specific yield was calculated using the formula
Fluorescence/OD=AU/gm DCW (the dry cell weight
factor is 0.3 gm/L/1OD600).
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